Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Piperacillin sodium |
Is a |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Piperacillin measurement |
Component |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Piperacillin poisoning |
Causative agent |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Accidental piperacillin poisoning |
Causative agent |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Intentional piperacillin poisoning |
Causative agent |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
forgiftning med piperacillin, uvist med hvilken hensigt |
Causative agent |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Piperacillin adverse reaction |
Causative agent |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Allergy to piperacillin |
Causative agent |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
piperacillin 1 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
piperacillin 2 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
piperacillin 4 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Piperacillin with tazobactam |
Is a |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
piperacillin 40 g pulver til injektionsvæske, rekonstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Product containing piperacillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
bivirkning af piperacillin og tazobactam |
Causative agent |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
piperacillin 4 g/tazobactam 500 mg pulver og solvens til infusionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Piperacillin with tazobactam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
piperacillin + tazobactam 36 g/4,5 g pulver til injektionsvæske, rekonstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Piperacillin sodium ns/tazobactam sodium ns injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Product containing piperacillin and tazobactam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Accidental piperacillin poisoning |
Causative agent |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Intentional piperacillin poisoning |
Causative agent |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
allergi over for piperacillin og tazobactam |
Causative agent |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Allergy to piperacillin |
Causative agent |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
allergi over for piperacillin og tazobactam |
Causative agent |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
allergi over for piperacillin og tazobactam |
Causative agent |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
3 |
allergi over for piperacillin og tazobactam |
Causative agent |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
2 |
Piperacillin and tazobactam |
Is a |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Piperacillin and tazobactam |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Piperacillin sodium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Piperacillin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Piperacillin- and tazobactam-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Piperacillin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Piperacillin and tazobactam only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Product containing only piperacillin and tazobactam in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Piperacillin anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Product containing only piperacillin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Product containing piperacillin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Piperacillin and tazobactam desensitisation therapy |
Using substance (attribute) |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
3 |
Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piperacillin (as piperacillin sodium) 2 gram and tazobactam (as tazobactam sodium) 250 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely piperacillin (as piperacillin sodium) 2 gram and tazobactam (as tazobactam sodium) 250 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |
Piperacillin therapy |
Direct substance |
True |
Piperacillin (substance) |
Inferred relationship |
Some |
1 |